These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2013850)

  • 21. Phenylboronic-Acid-Based Polymeric Micelles for Mucoadhesive Anterior Segment Ocular Drug Delivery.
    Prosperi-Porta G; Kedzior S; Muirhead B; Sheardown H
    Biomacromolecules; 2016 Apr; 17(4):1449-57. PubMed ID: 26963738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of chemical structure to corneal penetration and influence of low-viscosity solution on ocular bioavailability.
    Grass GM; Robinson JR
    J Pharm Sci; 1984 Aug; 73(8):1021-7. PubMed ID: 6491903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bioavailability of drugs applied to the eye externally].
    Sieradzki E
    Klin Oczna; 1991 Jan; 93(1):34-6. PubMed ID: 2046287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mathematical model for ocular tear and solute balance.
    Zhu H; Chauhan A
    Curr Eye Res; 2005 Oct; 30(10):841-54. PubMed ID: 16251121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Model of transient drug diffusion across cornea.
    Zhang W; Prausnitz MR; Edwards A
    J Control Release; 2004 Sep; 99(2):241-58. PubMed ID: 15380634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.
    Jiao J
    Adv Drug Deliv Rev; 2008 Dec; 60(15):1663-73. PubMed ID: 18845195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Vehicle Physicochemical Properties on Modeling-Based Predictions of Cyclosporine Ophthalmic Emulsion Bioavailability and Tear Film Breakup Time.
    Walenga RL; Babiskin AH; Zhang X; Absar M; Zhao L; Lionberger RA
    J Pharm Sci; 2019 Jan; 108(1):620-629. PubMed ID: 30385283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery.
    Kaur IP; Smitha R
    Drug Dev Ind Pharm; 2002 Apr; 28(4):353-69. PubMed ID: 12056529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of ocular drug penetration.
    Sasaki H; Yamamura K; Mukai T; Nishida K; Nakamura J; Nakashima M; Ichikawa M
    Crit Rev Ther Drug Carrier Syst; 1999; 16(1):85-146. PubMed ID: 10099899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.
    Liu R; Liu Z; Zhang C; Zhang B
    J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimizing systemic absorption of topically administered ophthalmic drugs.
    Urtti A; Salminen L
    Surv Ophthalmol; 1993; 37(6):435-56. PubMed ID: 8100087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of the ocular bioavailability of timolol by sorbic acid.
    Higashiyama M; Inada K; Ohtori A; Tojo K
    Int J Pharm; 2004 Mar; 272(1-2):91-8. PubMed ID: 15019072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of intracanalicular collagen implants on the absorption of topically applied sodium fluorescein.
    Unterman SR; Reidy JJ; Hill JH; Kaufman HE
    Cornea; 1991 Nov; 10(6):516-8. PubMed ID: 1782780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ocular tolerance of absorption enhancers in ophthalmic preparations.
    Furrer P; Mayer JM; Plazonnet B; Gurny R
    AAPS PharmSci; 2002; 4(1):E2. PubMed ID: 12049486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fabrication of a drug delivery system that enhances antifungal drug corneal penetration.
    Li J; Li Z; Liang Z; Han L; Feng H; He S; Zhang J
    Drug Deliv; 2018 Nov; 25(1):938-949. PubMed ID: 29658325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: Mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability.
    Zeng W; Li Q; Wan T; Liu C; Pan W; Wu Z; Zhang G; Pan J; Qin M; Lin Y; Wu C; Xu Y
    Colloids Surf B Biointerfaces; 2016 May; 141():28-35. PubMed ID: 26820107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corneal pharmacokinetics of topically applied azithromycin and clarithromycin.
    Kuehne JJ; Yu AL; Holland GN; Ramaswamy A; Taban R; Mondino BJ; Yu F; Rayner SA; Giese MJ
    Am J Ophthalmol; 2004 Oct; 138(4):547-53. PubMed ID: 15488779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of viscosity on tear drainage and ocular residence time.
    Zhu H; Chauhan A
    Optom Vis Sci; 2008 Aug; 85(8):715-25. PubMed ID: 18677227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacokinetics of the anterior eye].
    Bell K; Pfeiffer N; Grus FH
    Ophthalmologe; 2014 Feb; 111(2):107-12. PubMed ID: 24337342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of chitosan and of N-carboxymethylchitosan on intraocular penetration of topically applied ofloxacin.
    Di Colo G; Zambito Y; Burgalassi S; Nardini I; Saettone MF
    Int J Pharm; 2004 Apr; 273(1-2):37-44. PubMed ID: 15010128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.